SCHEMBL3631016

SCHEMBL3631016

Cn1c(CNC(=O)Nc2ccc(F)cc2)nc(-c2ccncn2)cc1=O.Cn1c(CNC(=O)Nc2ccccc2)nc(-c2ccncn2)cc1=O

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.44
POLB P06746 1/20 0.44
MAOB P27338 1/20 0.44
RAB9A P51151 1/20 0.44
GSK3B P49841 6/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2D6 P10635 2/20 0.44
CSNK1A1 P48729 1/20 0.44
GSK3A P49840 1/20 0.44
CYP3A4 P08684 4/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.42
HTT P42858 1/20 0.42
NAMPT P43490 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3274051 0.96 GSK3B (0.47) GSK3BCYP1A2CYP2D6CSNK1A1GSK3A
SCHEMBL3277629 0.94 CYP3A4 (0.47) NPC1RAB9AGSK3BCYP1A2CYP2D6
SCHEMBL3279276 0.83 GSK3B (0.48) GSK3BCYP1A2CYP2D6CSNK1A1GSK3A
SCHEMBL3273306 0.81 GSK3B (0.50) GSK3BCYP1A2CYP2D6CYP3A4MEN1
SCHEMBL3280874 0.79 ROCK2 (0.51) GSK3BCYP1A2CYP2D6CSNK1A1GSK3A
SCHEMBL3273879 0.77 GSK3B (0.43) GSK3BCYP1A2CYP2D6CSNK1A1GSK3A
SCHEMBL3273287 0.76 POLB (0.52) POLBRAB9AGSK3BCYP1A2CYP2D6
SCHEMBL3273968 0.76 GSK3B (0.52) GSK3BCYP1A2CYP2D6CSNK1A1GSK3A
SCHEMBL3273819 0.76 GAA (0.53) NPC1RAB9AGSK3BCYP1A2CYP2D6
SCHEMBL3274517 0.75 ROCK2 (0.48) GSK3BCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2148866-A2 ARYLAMIDE PYRIMIDONE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Sanofi-Aventis (FR) 2010-02-03 EP claimed
WO-2008155669-A2 ARYLAMIDE PYRIMIDONE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SANOFI-AVENTIS (FR) 2008-12-24 WO claimed